<DOC>
	<DOCNO>NCT02518568</DOCNO>
	<brief_summary>The purpose study investigate pharmacokinetics serum iron single oral administration 160 mg ( 2 tablet 80 mg ) V0355 woman iron deficiency anaemia .</brief_summary>
	<brief_title>Ferrous Sulphate Supplement ( V0355 ) Women With Iron Deficiency Anaemia</brief_title>
	<detailed_description />
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Anemia , Iron-Deficiency</mesh_term>
	<mesh_term>Deficiency Diseases</mesh_term>
	<criteria>Women 1845 year inclusive iron deficiency anaemia haemoglobin level 85 g/L 105 g/L serum ferritin level &lt; 15 Âµg/L D14 +/ 7 day menstruation cycle day pharmacokinetic evaluation Anaemia related cause iron deficiency particularly inflammatory anaemia , anaemia due marrow failure , haemopathy , haemoglobinopathy ( sickle cell disease , thalassemia ) , haemolytic anaemia , anaemia due acute haemorrhage , anaemia relate chronic renal failure , Haemochromatosis iron overload secondary origin ( blood transfusion ) , Long term treatment know modify iron absorption , Gastro duodenal ulcer , Inflammatory bowel disease digestive disease could modify iron absorption , Serious progressive disease ( cardiac , pulmonary , hepatic , renal , haematological , malignancy , autoimmune disease , infectious disease neuropsychiatric disorder ) , Surgery undergone within 1 month prior selection visit surgery plan study realization .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>